Who do I believe? Driving me nuts!😱
This data was interesting as an early proof of concept.
Of note, this analysis is ex-vivo. Essentially this concept/theory arose from studies in a petri dish environment that mimics some of the cellular function pathways seen in CML.
It is tough to translate this to clinical practice, as this environment is a simulation, a "perfect and predictable cellular world" with carefully chosen features to not skew results (quite the opposite of an actual human body). There also does not seem to be any follow up after 2004 (this is an incomplete study).
Additionally, the doses/regimen needed to show any kinetic differences are super small and do not reflect what may, in theory, work in a person since the cellular environment is so microscopic and nowhere near as complex as an animal or person.
Usually these types of studies need to be employed in animal models, followed by early phase I in humans to suggest clinical benefit in man.